[APLS] YoY Quarter Result on 31-Dec-2017 [#Q4]

Stock
[APLS] Apellis Pharmaceuticals, Inc.
Announcement Date
19-Mar-2018
Financial Year
2017
Quarter
31-Dec-2017 [#Q4]
Profit Trend
QoQ- -57.75%
YoY- -175.77%
Quarter Report
APLS's Result
APLS's Financial Summary
View:
Show?
Quarter Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 250,000 -142 12 12 0 0 0 -
PBT 80,110 -113,217 -36,459 -18,256 -6,620 -6,947 -2,884 -
Tax 2 3,981 2,383 -17,896 -6,679 1,269 -195 -
NP 78,265 -113,217 -36,459 -18,256 -6,620 -8,216 -2,689 -
Tax Rate -0.00% - - - - - - -
Total Cost 171,735 113,075 36,471 18,267 6,620 8,216 2,689 99.80%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin 31.31 79,646.45 -315,885.24 -158,169.26 0.00 0.00 0.00 -
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS 0.99 -1.54 -0.65 -0.36 -0.37 -0.45 -0.15 -
EPS Diluted 0.99 -1.54 -0.63 -0.36 -0.37 -0.45 -0.15 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.